Comments: US HB6400 | 2023-2024 | 118th Congress

Bill Title: To amend title XVIII of the Social Security Act to extend eligibility for certain payment increases for biosimilar biological products under the Medicare program.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Introduced) 2023-11-17 - Referred to the Subcommittee on Health. [HB6400 Detail]

Text: Latest bill text (Introduced) [PDF]

PolitiCorps Conversations

Start PolitiCorps Debate
TitlePolitiCorpsAccessCommentsViewsLast Post
There are no visible public or private PolitiCorps discussions concerning the 2023 US Congress HB6400 at this time.

Social Comments on US HB6400

feedback